Huvepharma receives conditional license for turkey coccidiosis vaccine
USDA’s Center for Veterinary Biologics has granted Huvepharma a conditional license for the manufacturing and sale of a new turkey coccidiosis vaccine.
USDA’s Center for Veterinary Biologics has granted Huvepharma a conditional license for the manufacturing and sale of a new turkey coccidiosis vaccine.
The parasitic disease coccidiosis remains one of the most economically significant diseases for turkeys. In 2023, coccidiosis ranked 10th in a US turkey industry survey of 38 health issues. Unfortunately, it often goes unnoticed.
